Skip to content

Price / book at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
3.5×-0.3×
Labcorp Holdings logo
Labcorp HoldingsLH
2.5×+0.2×
IQVIA logo
IQVIAIQV
4.6×-0.6×
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
4.1×+2.3×
Veeva Systems logo
Veeva SystemsVEEV
3.5×-2.5×
Medline, Inc.
 logo
Medline, Inc. MDLN
3.2×

Other financials

Income statement

See full
Revenue$706.6M+26.5%
Operating income$141.5M+24.6%
Net income$123.9M+8.1%
EPS (diluted)$4.28+16.6%

Balance sheet

See full
Cash & equivalents$652.7M+47.9%
Total debt$146.1M-2.8%
Total equity$598.3M+0.8%
Total assets$2.1B+12.2%

Cash flow

See full
Operating cash flow$151.8M+20.6%
CapEx$6.8M-31.8%
Free cash flow$145.0M+25.1%

Valuation

See full
Market cap$13.14B+46.8%
Enterprise value$12.64B+45.9%
P/E28.6×+7.0×
P/S4.9×+0.8×

Profitability

See full
Operating margin21%-0.1pp
Net margin17.2%-2.1pp
FCF margin26.5%+1.5pp

Returns & leverage

See full
Return on equity77.3%+11.4pp
Debt / equity0.2×0.0×
Current ratio0.8×+0.1×

Where this comes from

Calculated from Medpace Holdings, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medpace Holdings, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medpace Holdings, Inc.'s price / book?
Medpace Holdings, Inc. (MEDP) reported price / book of 22.8× in Q1 2026.
How has Medpace Holdings, Inc.'s price / book changed year-over-year?
Medpace Holdings, Inc.'s price / book increased by 45.7% year-over-year, from 15.6× to 22.8×.
What is the long-term trend for Medpace Holdings, Inc.'s price / book?
Over 5 years (2020 to 2025), Medpace Holdings, Inc.'s price / book has grown at a 40.9% compound annual growth rate (CAGR), from 6.2× to 34.5×.
What does price / book mean?
How the market price compares to the company's accounting net worth.
How do you interpret price / book?
Below 1.0 can flag a market discount to book value (common for distressed or asset-heavy firms); high values reflect intangible value the balance sheet doesn't capture. Most informative for financials and asset-heavy businesses.
How does price / book compare across companies?
A core valuation gauge for banks and insurers; weak for asset-light firms where book value understates economic value.